全球掌性管柱層析法市場:成長，趨勢，及預測(2020年∼2025年)

全球掌性管柱層析法市場主要成長要素，是在製藥及生物科技、其他產業的掌性層析法的用途增加，由於高的政府支出，資金籌措，及輔助金，製藥及生物科技產業使用先進層析法，也提高該市場的需求。再加上醫藥品的認證的層析法研究的重要性高漲，和對生命科學企業的研究開發的高額投資等，也推動該市場的成長。

本報告提供全球掌性管柱層析法市場的相關調查，市場機會和趨勢，成長及阻礙因素，各類型、用途、終端用戶、地區的市場分析，競爭情形，主要企業的簡介等資訊。

目錄

第1章 簡介

• 調查成果
• 調查的前提條件
• 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

• 市場概況
• 市場成長要素
  • 層析法設備的技術的進步
  • 醫藥品核準的層析法為基礎的研究的重要性
• 市場阻礙因素
  • 設備的價格上升
• 波特的五力分析

第5章 市場區隔

• 各類型
  • 已填充
  • 空
• 各用途
  • 氣相層析法(GC)
  • 液體層析法(LC)
  • 薄層層析法(TLC)
  • 超臨界流體層析法(SFC)
• 各終端用戶
  • 製藥及生物科技企業
  • 醫院/診療所
  • 食品及飲料產業
  • 其他
• 各地區
  • 北美
  • 歐洲
  • 亞太地區
  • 中東、非洲
  • 南美

第6章 競爭情形

• 企業簡介
  • Merck & Co., Inc.
  • 株式會社島津製作所
  • Daicel Corporation
  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies
  • Waters Corporation
  • Bio-Rad Laboratories, Inc.
  • Phenomenex, Inc.
  • GE Healthcare

第7章 市場機會及今後趨勢

The major factors attributing to the growth of the chiral chromatography columns market are the increasing applications of chiral chromatography in pharmaceutical and biotechnology and in other industries. Higher government expenditure, funding, and subsidies have encouraged pharmaceutical and biotechnology industries to use the advanced chromatographic method that is propelling the market growth.

In addition, the rising importance of chromatography studies in approval of drugs and heavy investment in research and development by life science firms which are playing key roles in taking the chiral chromatography columns market to the next level, among them one is on-going developments related to chiral chromatography columns and its technology which are expected to further drive the growth of global chiral chromatography columns market.

Key Market Trends

Pre Packed Column Segment is Expected to Hold the Largest Market Share in the Chiral Chromatography Columns Market

The pre-packed column is expected to dominate the market over the forecast period, attributed to augmenting demand for analytical volumes in industries and laboratories. Virus titer reduced testing, increased demand for antibody purification and vaccines, and recombinant proteins have surged the pre-packaged column chromatography market.

Cost-effective purification and process development of biological drugs are also attributed to the growth of this segment. Another main factor affecting the dynamics of the industry is the fast growth of the pharmaceutical, biotechnology, proteomics & life science market.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall chiral chromatography columns market, throughout the forecast period. This is owing to factors such as the extension of both the international pharmaceutical and biotechnology industries are among the major factors.

In North America region, the United States holds the largest market share owing to the different factors such as novel advancements, a significant rise in unique product launch and an increasing number of chromatography-related conferences that are driving chromatography market growth.

Competitive Landscape

The chiral chromatography columns market is moderately competitive and consists of major players. In terms of market share, few of the major players are currently dominating the market. Ans some prominent players are vigorously making acquisitions and new product launches with the other companies to consolidate their market positions across the globe. Some of the companies which are currently dominating the market are Merck, Shimadzu Corporation, Daicel Corporation, Thermo Fisher Scientific, Inc., and Agilent Technologies.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Deliverables
• 1.2 Study Assumptions
• 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Advancement in the Technology of Chromatography Instruments
  • 4.2.2 Significance of Chromatography Based Studies in Drug Approval
• 4.3 Market Restraints
  • 4.3.1 Rising Price of Equipment
• 4.4 Porter's Five Force Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

• 5.1 By Type
  • 5.1.1 Pre Packaed Column
    • 5.1.1.1 Preparative Column
    • 5.1.1.2 Analytical Column
  • 5.1.2 Empty Column
• 5.2 By Application
  • 5.2.1 Gas Chromatography (GC)
  • 5.2.2 Liquid Chromatography (LC)
  • 5.2.3 Thin-layer chromatography (TLC)
  • 5.2.4 Supercritical Fluid Chromatography (SFC)
• 5.3 By End User
  • 5.3.1 Pharmaceutical and Biotechnology Companies
  • 5.3.2 Hospital/Clinincs
  • 5.3.3 Food & beverages Industry
  • 5.3.4 Others
• 5.4 Geography
  • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
  • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
  • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
  • 5.4.4 Middle-East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle-East and Africa
  • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Merck KGaA
  • 6.1.2 Shimadzu Corporation
  • 6.1.3 Daicel Corporation
  • 6.1.4 Thermo Fisher Scientific, Inc.
  • 6.1.5 Agilent Technologies
  • 6.1.6 Waters Corporation
  • 6.1.7 Bio-Rad Laboratories, Inc.
  • 6.1.8 Phenomenex, Inc.
  • 6.1.9 GE Healthcare

7 MARKET OPPORTUNITIES AND FUTURE TRENDS